Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
7.31M
-
Shares change
-
+1.45M
-
Total reported value, excl. options
-
$213M
-
Value change
-
+$42.5M
-
Put/Call ratio
-
0.66
-
Number of buys
-
30
-
Number of sells
-
-12
-
Price
-
$29.15
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q4 2017
66 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2017.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.31M shares
of 100M outstanding shares and own 7.28% of the company stock.
Largest 10 shareholders include FMR LLC (3.59M shares), MORGAN STANLEY (496K shares), Balyasny Asset Management LLC (409K shares), PERCEPTIVE ADVISORS LLC (350K shares), SPHERA FUNDS MANAGEMENT LTD. (339K shares), Tekla Capital Management LLC (310K shares), CREDIT SUISSE AG/ (290K shares), BlackRock Inc. (152K shares), LAZARD ASSET MANAGEMENT LLC (151K shares), and PointState Capital LP (145K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.